Status:
COMPLETED
Biofeedback of Glucose in Non-diabetic Participants
Lead Sponsor:
Klick Inc.
Conditions:
Blood Glucose
Biofeedback
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc...
Detailed Description
The purpose of this research is to examine whether self-monitoring and biofeedback of glucose levels improves health outcomes in non-diabetic participants. All participants will receive a continuous f...
Eligibility Criteria
Inclusion
- \-
Exclusion
- Below the age of 18 years
- Diagnosis of any known chronic or acute medical disease (e.g., diabetes, cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)
- Diagnosis of any known neurological disease or psychological disorder (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)
- Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)
- Suspected or confirmed pregnancy
- Currently breastfeeding
- Use of antibiotics in the three months prior to enrollment
- Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study
Key Trial Info
Start Date :
July 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04077203
Start Date
July 16 2019
End Date
November 30 2019
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klick Inc.
Toronto, Ontario, Canada, M4W 3R8